Skip to Main Content

Author Details

Thibaut Vausselin
CNRS, INSERM, Institut Pasteur de Lille, Center for Infection and Immunity of Lille
2010
14
9
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36007070An Arginine-Rich Motif in the ORF2 capsid protein regulates the hepatitis E virus lifecycle and interactions with the host cell.PLoS Pathog2022
35587469Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice.PLoS Pathog2022
32861832Safety and Efficacy of Avaren-Fc Lectibody Targeting HCV High-Mannose Glycans in a Human Liver Chimeric Mouse Model.Cell Mol Gastroenterol Hepatol2021
34922563BacMam virus-based surface display for HCV E2 glycoprotein induces strong cross-neutralizing antibodies and cellular immune responses in vaccinated mice.Infect Agent Cancer2021
29760472Author Correction: SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses.Sci Rep2018
29391557SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses.Sci Rep2018
27412600Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.J Virol2016
25502878Boronic acid-modified lipid nanocapsules: a novel platform for the highly efficient inhibition of hepatitis C viral entry.Nanoscale2015
26561856Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.PLoS One2015
26284260High-Throughput Minigenome System for Identifying Small-Molecule Inhibitors of Ebola Virus Replication.ACS Infect Dis2015
26041282New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.J Virol2015
23348596The antimalarial ferroquine is an inhibitor of hepatitis C virus.Hepatology2013
24180242Phenylboronic-acid-modified nanoparticles: potential antiviral therapeutics.ACS Appl Mater Interfaces2013
20932226Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response.Expert Opin Biol Ther2010
  • 1 - 14 of 14

Recommended Authors

Mir M Khalid
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 3
Taha Y Taha
Gladstone Institutes
Career Start Year 2015
Number of shared co-authors 1
Andreas S Puschnik
Stanford University School of Medicine
Career Start Year 2013
Number of shared co-authors 1
Ragunath Singaravelu
Ottawa Hospital Research Institute
Career Start Year 2010
Number of shared co-authors 0
Kris M White
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2010
Number of shared co-authors 6
Holly Ramage
Sidney Kimmel Medical College, Thomas Jefferson University
Career Start Year 2009
Number of shared co-authors 1
Manu Anantpadma
Boston University
Career Start Year 2009
Number of shared co-authors 3
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 3
Mohsan Saeed
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Gregory Camus
Gilead Sciences Inc.
Career Start Year 2006
Number of shared co-authors 1
Xuexiang Zhang
Baruch S. Blumberg Institute
Career Start Year 2005
Number of shared co-authors 0
Vanessa M Cowton
MRC-University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 2005
Number of shared co-authors 1
Shirit Einav
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 1
Gopinath M Subramanian
John Hunter Children's Hospital
Career Start Year 2002
Number of shared co-authors 0
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 6
Masaya Sugiyama
Research Institute, National Center for Global Health and Medicine
Career Start Year 2000
Number of shared co-authors 0
Mansun Law
The Scripps Research Institute
Career Start Year 1998
Number of shared co-authors 0
Becket Feierbach
Gilead Sciences Inc.
Career Start Year 1997
Number of shared co-authors 0
Renee C Ireton
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1997
Number of shared co-authors 1
Pei-Yong Shi
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 2
Keith Meyer
Saint Louis University
Career Start Year 1994
Number of shared co-authors 0
Brett D Lindenbach
Yale University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Raymond T Chung
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1992
Number of shared co-authors 0
Robert A Davey
Boston University
Career Start Year 1991
Number of shared co-authors 3
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1988
Number of shared co-authors 2
Arvind H Patel
MRC-University of Glasgow Centre for Virus Research
Career Start Year 1987
Number of shared co-authors 4
Albrecht von Brunn
Max-von-Pettenkofer Institute, Ludwig-Maximilians-University (LMU) Munich
Career Start Year 1983
Number of shared co-authors 0
Paul J Pockros
Scripps Clinic and Scripps Translational Science Institute
Career Start Year 1982
Number of shared co-authors 0
Charles M Rice
Rockefeller University
Career Start Year 1981
Number of shared co-authors 2
Aleem Siddiqui
University of California
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Megan L Shaw
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Sira C G??nther
Institute of Medical Virology, University of Zurichgrid.0.3
Co-authored papers 2
Lars Pache
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Sebastian Giese
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Co-authored papers 2
Alexandra H Dudek
Institute of Virology, Medical Center, University of Freiburg
Co-authored papers 2
Yap Ching Chew
Zymo Research Corporation
Co-authored papers 2
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 2
Martin Schwemmle
Institute of Virology, Medical Center - University of Freiburg
Co-authored papers 2
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Co-authored papers 2
Daria Khokhlova-Cubberley
Co-authored papers 2
Dominik Dornfeld
Institute of Virology, Medical Center University of Freiburg
Co-authored papers 2
Cécile Lecoeur
Co-authored papers 1
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Release 1.2